Exendin (9-39) amide, GLP-1 receptor antagonist ab141101 from Abcam

DLSKQMEEEA VRLFIEWLKN GGPSSGAPPP S

Discovery Drive

Cambridge Biomedical Campus

Cambridge CB2 0AX

United Kingdom

Phone: +44 (0) 1223 696000 (option 1)
+44 (0) 1223 696000 (option 2)
+44 (0) 1223 771600

(1) Weight Loss Reverses Obesity-Associated Impairments in Acute Gastrointestinal Stretch-Induced Suppression of Food Intake and Glucose HomeostasisMolecular MetabolismSeptember 25, 2025Maigen Bethea, Tyler Cook, Marwa Mommandi, Andrew McClennan, Allison Martin, Jasmine J. Hendrix, Chelsea R. Hutch, Alfor Lewis, Randy J. Seeley, Henning Fenselau, et al.of methylcellulose or mannitol. To examine the necessity of GLP-1R signaling, Exendin-9-39 (Abcam, ab141101) at 600 nmol/kg or saline was administered via intraperitoneal (IP) injection 15 min before mannitol

(2) Geniposide Attenuates Hyperglycemia-Induced Oxidative Stress and Inflammation by Activating the Nrf2 Signaling Pathway in Experimental Diabetic RetinopathyOxidative Medicine and Cellular LongevityDecember 13, 2021Yuanyuan Tu, Lele Li, Linling Zhu, Yang Guo, Shu Du, Yuxing Zhang, Zhenzhen Wang, Yuting Zhang, Manhui ZhumM, 24 h) (#A7250, Merck, USA) [26] and GLP-1R antagonist exendin (9-39) (EX-9) (200 nmol/l, 1 h) (#ab141101, Abcam, UK) [28] were used to treat the cells before HG or GEN administration. After certain treatments,

(3) Gastrointestinal Distension by Pectin-Containing Carbonated Solution Suppresses Food Intake and Enhances Glucose Tolerance via GLP-1 Secretion and Vagal Afferent ActivationFront Endocrinol (Lausanne)June 8, 2021Kento Ohbayashi, Yukiko Oyama, Chiharu Yamaguchi, Toshiki Asano, Toshihiko Yada, Yusaku Iwasakitime was expressed. To examine the involvement of GLP-1R signaling, exendin(9–39) amide [Ex(9–39), ab141101, Abcam, Cambridge, UK] at 600 nmol/kg or saline (5 ml/kg) was ip administered with a single shot at

(4) Improvement of hepatocyte engraftment by co‐transplantation with pancreatic islets in hepatocyte transplantationJournal of Tissue Engineering and Regenerative MedicineApril 1, 2021Yoshikatsu Saitoh et al.Abcam) (Anti‐VEGF group, n = 5), or coculture supernatant together with 50 ng/ml GLP‐1 antagonist (ab141101, Abcam) (GLP‐1 antagonist group, n = 5). The amounts of anti‐VEGF antibody and GLP‐1 antagonist to sufficiently

(5) DPP (Dipeptidyl Peptidase)-4 Inhibitor Attenuates Ang II (Angiotensin II)–Induced Cardiac Hypertrophy via GLP (Glucagon-Like Peptide)-1–Dependent Suppression of Nox (Nicotinamide Adenine Dinucleotide Phosphate Oxidase) 4-HDAC (Histone Deacetylase) 4 PathwayHypertensionApril 1, 2020Kosuke Okabe et al.(Angiotensin II; A9525, Sigma-Aldrich, St Louis, MO), exendin-4 (E7144, Sigma-Aldrich), exendin-3 (ab141101, Abcam, Cambridge, United Kingdom), and GKT137831 (17764, Cayman Chemical, Ann Arbor, MI) were commercially

Exendin (9-39) amide, GLP-1 receptor antagonist from Abcam